Progyny, Inc.

Progyny, Inc. Q3 2025 Earnings Recap

PGNY Q3 2025 November 8, 2025

Progyny reported strong Q3 results, exceeding revenue and profitability guidance while significantly expanding its client base, resulting in a quarterly revenue guidance increase of over $70 million.

Earnings Per Share Beat
$0.45 vs $0.39 est.
+15.4% surprise
Revenue Miss
313346000 vs 314259750 est.
-0.3% surprise

Market Reaction

1-Day +0.0%
5-Day +9.16%
30-Day +9.75%

Key Takeaways

  • Q3 revenue and adjusted EBITDA surpassed expectations, leading to raised full-year guidance for the third consecutive quarter.
  • Acquired over 80 new logos and 900,000 covered lives during the recent selling season, demonstrating strong demand for family-building and women's health solutions.
  • Achieved nearly 100% renewal rate of existing clients and expanded benefits for nearly 30% of clients for 2026, validating market leadership.
  • New services in pregnancy postpartum and menopause have gained notable traction, adding access for 2.7 million members next year.
  • White House initiative to expand access to fertility care represents a positive outlook for Progyny, especially in the small and midsized employer market.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit PGNY on AllInvestView.

Get the Full Picture on PGNY

Track Progyny, Inc. in your portfolio with real-time analytics, dividend tracking, and more.

View PGNY Analysis